It is a healthcare private limited company based in Mumbai, Maharashtra, India, established in 1955.
1955 | Mumbai, Maharashtra, India | ActiveAlarsin Pharmaceuticals (India) Private Limited, a active private limited company, was established on 23 July 1955 in Mumbai, Maharashtra, India. Engaging in ayurvedic products & services within the healthcare sector, it holds CIN: U24239MH1955PTC009609. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.60 M and a paid-up capital of ₹0.10 M.
Formerly known as Alarsin Pharmaceuticals (India) Limited. It upholds a compliant status. Its leadership includes Amar Kunjbihari Patel (Director), Palash Keshavlal Patel (Director), Satish Upendra Almaula (Director). Past directors included Shantilal Narotamdas Patel. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Alarsin House A/32 Streetno 3 Opp Esic Hospital Midc Marol Andheri East, Mumbai, Maharashtra, 400093.
U24239MH1955PTC009609
009609
23 July 1955
₹0.60 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Alarsin Pharmaceuticals (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amar Kunjbihari Patel | Director | 14 Feb 2005 | Current |
| Palash Keshavlal Patel | Director | 15 Oct 1998 | Current |
| Satish Upendra Almaula | Director | 01 Dec 1974 | Current |
| Ajay Kunjbihari Patel | Director | 15 Jun 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Jul 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Alarsin Pharmaceuticals (India) Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 8.72% increase. The company also saw a slight improvement in profitability, with a 9.46% increase in profit. The company's net worth Soared by an impressive increase of 10.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Alarsin Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Alarsin Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Alarsin Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alarsin Pharmaceuticals (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Alarsin Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Alarsin Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity Amar Kunjbihari Patel was appointed as a Director was appointed as a Director on 14 Feb 2005 & has been associated with this company since 20 years 10 months . was completed.
Progress on Ajay Kunjbihari Patel was appointed as a Director was appointed as a Director on 15 Jun 2004 & has been associated with this company since 21 years 6 months . was documented.
Progress on Palash Keshavlal Patel was appointed as a Director was appointed as a Director on 15 Oct 1998 & has been associated with this company since 27 years 2 months . was documented.
Progress on Satish Upendra Almaula was appointed as a Director was appointed as a Director on 01 Dec 1974 & has been associated with this company since 51 years 27 days . was documented.
The CIN of Alarsin Pharmaceuticals (India) Private Limited is U24239MH1955PTC009609.
Alarsin Pharmaceuticals (India) Private Limited is headquartered at Alarsin House A/32 Streetno 3 Opp Esic Hospital Midc Marol Andheri East, Mumbai, Maharashtra, 400093.
Alarsin Pharmaceuticals (India) Private Limited was incorporated on 23 July 1955.
The current directors of Alarsin Pharmaceuticals (India) Private Limited are
The primary industry of Alarsin Pharmaceuticals (India) Private Limited is Healthcare.
Alarsin Pharmaceuticals (India) Private Limited is unlisted.
The authorized capital of Alarsin Pharmaceuticals (India) Private Limited is ₹0.60 M, and the paid-up capital is ₹0.10 M.
The compliance status of Alarsin Pharmaceuticals (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX